Selected literature

The evidence base for these recommendations is drawn from the following sources:

  1. National Osteoporosis Foundation (NOF) (2005 revision) Physician’s Guide to Prevention and Treatment of Osteoporosis.
  2. Dawson-Hughes B, Heaney RP, Holick M, Lips R, Meunier P, Vieth R (2005) Estimates of optimal Vitamin D status. Osteoporosis Int 16:713-716.
  3. Mark R Forwood (2000) Exercise Recommendations for Osteoporosis: A position statement of the Australian and New Zealand Bone and Mineral Society. Australian Family Physician 29(8):761-764.
  4. Australia and New Zealand Bone and Mineral Society (September 2006): Calcium & Bone Health – Draft position paper.
  5. National Osteoporosis Foundation (July 2007) Updated Recommendations for Calcium and Vitamin D Intake.
  6. Australia and New Zealand Bone and Mineral Society: Vitamin D & Bone Health in Australia & New Zealand, Position Statement.
  7. Black D, Delmas P, Eastell R, Reid I R, Boonen S, Cauley J, Cosman, F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Huilin H, Caminis J, Tong K Rosario-Jansen T, Krasnow J, Hue T, Sellmeyer D, Eriksen E F, Cumming S, for the HORIZON Pivotal Fracture Trial (May 2007) Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis. NEMJ 356(10):1809-1822.
  8. Risks and Benefits of Estrogen plus Progestin in Healthy Postmenopausal Women: Principal Results from the Women’s Health Initiative Randomised Controlled Trial. JAMA 288(3):321-333, 2002.
  9. Effects of Conjugated Equine Estrogen in Postmenopausal Women with Hysterectomy: The Women’s Health Initiative Randomised Controlled Trial. JAMA 291(4):1701-1712, 2004.
  10. Siris, et al (Sep 2005) Skeletal Effects of Raloxifene after Eight Years: Results from the continuing outcomes relevant to Evista (CORE) study. J Bone Miner Res 20(9):1514-24.